CDKN2A and neoplasm: Moreover, the proportion of p16INK4a expressing fibroblasts (αSMA positive cells) in the tumour regions of mice treated with ABT-263 was lower than that in mice not treated with ABT-263 (Supplementary Fig. 11e).